Bio Port Korea Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	73,879	73,346	68,699
Revenue Growth (YoY)	-0.32%	6.77%	-
Cost of Revenue	53,999	52,411	49,616
Gross Profit	19,881	20,936	19,083
Selling, General & Admin	15,042	14,507	13,179
Research & Development	619.43	504.95	457.61
Amortization of Goodwill & Intangibles	26.82	9.48	9.48
Other Operating Expenses	225.15	163.69	133.25
Operating Expenses	16,693	15,696	14,164
Operating Income	3,188	5,240	4,919
Interest Expense	-336.04	-1,512	-2,108
Interest & Investment Income	517.48	517.44	408.99
Currency Exchange Gain (Loss)	218.6	544.78	206.96
Other Non Operating Income (Expenses)	-2,653	1,467	182.24
EBT Excluding Unusual Items	934.41	6,258	3,609
Gain (Loss) on Sale of Investments	-	18.23	-13.91
Gain (Loss) on Sale of Assets	-6.7	-924.59	-
Pretax Income	927.71	5,352	3,595
Income Tax Expense	3.29	1,240	225.62
Net Income	924.43	4,112	3,369
Net Income to Common	924.43	4,112	3,369
Net Income Growth	-72.87%	22.04%	-
Shares Outstanding (Basic)	4	3	3
Shares Outstanding (Diluted)	5	4	4
Shares Change (YoY)	32.37%	1.04%	-
EPS (Basic)	234.33	1465.53	1347.75
EPS (Diluted)	234.33	1438.99	1302.58
EPS Growth	-82.05%	10.47%	-
Free Cash Flow	1,743	8,491	-1,253
Free Cash Flow Per Share	369.38	2372.83	-353.75
Gross Margin	26.91%	28.54%	27.78%
Operating Margin	4.32%	7.14%	7.16%
Profit Margin	1.25%	5.61%	4.91%
Free Cash Flow Margin	2.36%	11.58%	-1.82%
EBITDA	5,461	7,102	6,328
EBITDA Margin	7.39%	9.68%	9.21%
D&A For EBITDA	2,273	1,862	1,409
EBIT	3,188	5,240	4,919
EBIT Margin	4.32%	7.14%	7.16%
Effective Tax Rate	0.35%	23.16%	6.28%
Advertising Expenses	-	966.01	768.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.